- About Ximbio
- Benefits for
- Deposit Reagents
- Write Reviews
- News & Events
- Contact Us
- Cookies Policy
Ximbio is unifying the life science community to make research tools more widely and easily available, to accelerate research.
Ximbio is a business unit of Cancer Research Technology, owned by CRUK. CRT has been commercialising reagents generated by CRUK funded scientists, including mouse models, antibodies, cell lines and small molecules for over 25 years. Ximbio is a pro-academic website created to globalise the commercialisation of research tools. By launching Ximbio, scientists are able to use Ximbio as a marketing platform to maximise commercial opportunities for their reagents.
Researchers and technology transfer offices can virtually upload their reagents to the Ximbio website. This process is simple, quick and the first step in making reagents globally visible.
Users can share their experiences of the reagents listed on Ximbio. We aim to provide valuable information about the usefulness of the tool in a specific experiment and application. We encourage the sharing of both positive and negative reviews on products, both viewpoints add value when deciding on a product to use.
Here you will find our latest press releases, featured products, news and much more. In addition to the details of upcoming events hosted or attended by the Ximbio team.